Bromide

Bromide

SCHEMBL9435928

Br.N=C(S)NCCN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1054328 0.97
SCHEMBL28133806 0.94
Hydrochloric Acid SCHEMBL10656294 0.94
Hydrochloric Acid SCHEMBL7527399 0.94
Acrylamide SCHEMBL28565834 0.82 ALDH1A1 (0.41)
SCHEMBL7063422 0.81
SCHEMBL27008232 0.78 ALDH1A1 (0.30)
SCHEMBL27256476 0.73
SCHEMBL690044 0.71
SCHEMBL9749889 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118425526-A Analysis method, peptide antioxidant for mass spectrometry, and kit for mass spectrometry 株式会社岛津制作所 2024-08-02 CN claimed
CN-111919114-B Analysis method, peptide antioxidant for mass spectrometry, and kit for mass spectrometry 株式会社岛津制作所 2024-04-26 CN claimed
CN-111919114-A Analysis method, peptide antioxidant for mass spectrometry, and kit for mass spectrometry 株式会社岛津制作所 2020-11-10 CN claimed
CN-118425526-A Analysis method, peptide antioxidant for mass spectrometry, and kit for mass spectrometry 株式会社岛津制作所 2024-08-02 CN disclosed
CN-111919114-B Analysis method, peptide antioxidant for mass spectrometry, and kit for mass spectrometry 株式会社岛津制作所 2024-04-26 CN disclosed
CN-116574689-A Secretion anti-PP 1P k Hybridoma cell strain of antibody and application thereof 上海市血液中心 2023-08-11 CN disclosed
CN-111919114-A Analysis method, peptide antioxidant for mass spectrometry, and kit for mass spectrometry 株式会社岛津制作所 2020-11-10 CN disclosed
CN-100491397-C Methods and compositions for generating human monoclonal antibodies RAVEN BIOTECHNOLOGIES INC (US) 2009-05-27 CN disclosed
CN-1420893-A Method and compositions for generating human monoclonal antibodies RAVEN BIOTECHNOLOGIES INC (US) 2003-05-28 CN disclosed
US-5371073-A Collecting human colostrum, isolating immunoglobuln E binding factor, determining binding and synthesis suppressing activity CIBA-GEIGY CORPORATION (US) 1994-12-06 US disclosed
US-5272255-A Polypeptide factors from colostrum CIBA-GEIGY CORPORATION (US) 1993-12-21 US disclosed
EP-0259585-B1 MONOCLONAL ANTIBODIES SPECIFIC TO SURFACE RECEPTOR FOR IGE AND HYBRID CELL LINES PRODUCING THESE ANTIBODIES AND USE THEREOF Kishimoto, Tadamitsu, Prof. (JP) 1993-06-09 EP disclosed
EP-0190099-B1 POLYPEPTIDE FACTORS FROM COLOSTRUM CIBA-GEIGY AG (CH) 1993-04-28 EP disclosed
US-4866037-A Polypeptide factors from colostrum CIBA-GEIGY CORPORATION (US) 1989-09-12 US disclosed
EP-0259585-A1 Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof Kishimoto, Tadamitsu, Prof. (JP) 1988-03-16 EP disclosed
EP-0255547-A1 Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof Kishimoto, Tadamitsu, Prof. (JP) 1988-02-10 EP disclosed
EP-0254767-A1 Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof Kishimoto, Tadamitsu, Prof. (JP) 1988-02-03 EP disclosed
EP-0222360-A2 A method of producing a patient-specific cytotoxic reagent and composition Biotherapeutics Inc. (US) 1987-05-20 EP disclosed
EP-0190099-A2 Polypeptide factors from colostrum CIBA-GEIGY AG (CH) 1986-08-06 EP disclosed
EP-0181524-A2 Novel lymphokine Eisai Co., Ltd. (JP) 1986-05-21 EP disclosed